IDH Inhibitors Target Common Mutation in Glioma.
Sign Up to like & getrecommendations! Published in 2019 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-nd2019-007
Abstract: Mutant-selective IDH1 inhibitors engage their target in the brain and shrink glioma tumors with an acceptable safety profile, according to phase I trial data on three different drug candidates. However, some clinicians argue the drug… read more here.
Keywords: target common; inhibitors target; glioma; mutation glioma ... See more keywords